Glycemic control and weight loss benefits of fixed-ratio combinations of basal insulins and GLP1 receptor agonists in type 2 diabetes: A systematic review and network meta-analysis.
A recently indexed PubMed record relevant to peptide research. The displayed date may reflect indexing rather than final print publication. Review the original citation and study limitations.
Open original source ↗Collected Nov 1, 2026. Third-party data may change. Consult the original publication or registry for complete methods, findings and status.